Literature DB >> 32812181

Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events.

M den Braber-Ymker1, M C Vonk2, K Grünberg1, M Lammens1,3,4, I D Nagtegaal5.   

Abstract

OBJECTIVES: The pathogenesis of intestinal involvement in systemic sclerosis (SSc) is thought to be a sequential process (vascular, neuronal, and consecutive muscular impairment), but understanding of the underlying histological changes and how they translate to symptoms, is still lacking. Therefore, we systematically investigated histological characteristics of SSc in the intestines, compared to controls.
METHODS: Autopsy material from the small bowel and colon was used for histological semiquantitative evaluation of the vasculature, enteric nervous system, interstitial cells of Cajal (ICC), and muscle layers, using a combination of histochemical and immunohistochemical stainings, according to guidelines of the Gastro 2009 International Working Group.
RESULTS: Vascular changes were most frequently encountered, represented by intima fibrosis in both arteries and small vessels, and represented by venous dilatation. Second, generalized fibrosis of the circular muscle layer was significantly more found in SSc patients than in controls. Third, reduction of submucosal nerve fibers and myenteric neurons was shown in the colon of four SSc patients, which may explain severe symptoms of intestinal dysmotility. The density of myenteric ICC network was decreased in the small bowel of SSc patients.
CONCLUSIONS: The postulated sequential processes of intestinal involvement in SSc could not be supported by our histological evaluation. The interpatient diversity suggests that parallel processes occur, explaining the variety of histological features and clinical symptoms. Key Points • Histological analysis showed vascular changes, fibrosis in the muscularis propria, and reduction of the ENS and ICC network in the intestines of SSc patients. • Pathophysiological mechanisms leading to intestinal dysmotility in SSc may be parallel rather than sequential. • The interpatient diversity suggests parallel pathophysiological processes, explaining the variety of histological features and clinical symptoms.

Entities:  

Keywords:  Histology; Intestinal dysmotility; Pathogenesis; Systemic sclerosis

Mesh:

Year:  2020        PMID: 32812181      PMCID: PMC7895795          DOI: 10.1007/s10067-020-05325-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  The pathogenesis of systemic sclerosis.

Authors:  Tamiko R Katsumoto; Michael L Whitfield; M Kari Connolly
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

2.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

4.  The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease.

Authors:  S Cohen; R Fisher; W Lipshutz; R Turner; A Myers; R Schumacher
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

Review 5.  Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.

Authors:  Genevieve Gyger; Murray Baron
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 6.  Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.

Authors:  Kanyakorn Jaovisidha; M E Csuka; Urias A Almagro; Konrad H Soergel
Journal:  Semin Arthritis Rheum       Date:  2005-02       Impact factor: 5.532

7.  Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells.

Authors:  Jagmohan Singh; Vaibhav Mehendiratta; Francesco Del Galdo; Sergio A Jimenez; Sidney Cohen; Anthony J DiMarino; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

8.  Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility.

Authors:  Y Kawaguchi; Y Nakamura; I Matsumoto; E Nishimagi; T Satoh; M Kuwana; T Sumida; M Hara
Journal:  Ann Rheum Dis       Date:  2008-09-01       Impact factor: 19.103

9.  Practical and reproducible estimation of myenteric interstitial cells of Cajal in the bowel for diagnostic purposes.

Authors:  M den Braber-Ymker; S Heijker; M Lammens; I D Nagtegaal
Journal:  Neurogastroenterol Motil       Date:  2016-04-02       Impact factor: 3.598

10.  Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.

Authors:  I Marie; H Levesque; P Ducrotté; P Denis; J Benichou; M F Hellot; N Cailleux; X Le Loët; P Joly; P Lauret; H Courtois
Journal:  Arthritis Rheum       Date:  1998-10
View more
  1 in total

Review 1.  The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.

Authors:  Ioana Bratoiu; Alexandra Maria Burlui; Anca Cardoneanu; Luana Andreea Macovei; Patricia Richter; Gabriela Rusu-Zota; Ciprian Rezus; Minerva Codruta Badescu; Andreea Szalontay; Elena Rezus
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.